Pharmaceutical preparations containing (1R, 2R)-N-2-(2,3-Dihydrobenzofuran-4-yl)-cyclopropylmethylpropanamide, for the treatment or prevention of diseases of angiogenesis, diabetic retinopathy and diabetic macular edema, neurodegeneration, inflammation and cancer, depressive disorders, autism, and sleep disorders

'-2':7 '-4':11 '1r':4 '2':8 '2r':5 '3':9 'angiogenesi':22 'autism':35 'cancer':32 'contain':3 'cyclopropylmethylpropanamid':13 'depress':33 'diabet':23,26 'dihydrobenzofuran':10 'diseas':20 'disord':34,38 'edema':28 'inflamm':30 'macular':27 'n':6 'neurodegener':29 'pharmaceut':1 'prepar':2 'prevent':18 'retinopathi':24 'sleep':37 'treatment':16 'yl':12

TASIMELTEON

Owners

Goods & Services